Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study - Erica L. Mayer, Amylou C. Dueck, Miguel Martin, Gabor Rubovszky, Harold J. Burstein, Meritxell Bellet-Ezquerra, Kathy D. Miller, Nicholas Zdenkowski, Eric P. Winer, Georg Pfeiler, Matthew Goetz, Manuel Ruiz-Borrego, Daniel Anderson, Zbigniew Nowecki, Sibylle Loibl - Dissemin

Language
Login

Published in

Elsevier, The Lancet Oncology, 2(22), p. 212-222, 2021

DOI: 10.1016/s1470-2045(20)30642-2

Links

Tools

Export citation

Search in Google Scholar

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

Journal article published in 2021 by Erica L. Mayer, Amylou C. Dueck, Miguel Martin, Gabor Rubovszky, Harold J. Burstein, Meritxell Bellet-Ezquerra, Kathy D. Miller, Nicholas Zdenkowski, Eric P. Winer, Georg Pfeiler, Matthew Goetz, Manuel Ruiz-Borrego, Daniel Anderson, Zbigniew Nowecki, Sibylle Loibl and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO